You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
羅欣藥業(002793.SZ):注射用頭孢硫脒、注射用頭孢唑肟鈉中標贛粵豫鄂四省聯盟藥品帶量採購
格隆匯 04-05 16:25

格隆匯4月5日丨羅欣藥業(002793.SZ)公佈,近日,江西省醫藥採購服務平台發佈《關於公佈贛粵豫鄂四省聯盟藥品帶量採購中選結果的通知》,公司下屬子公司山東羅欣投標的注射用頭孢硫脒、注射用頭孢唑肟鈉中標。

注射用頭孢硫脒適應症:用於敏感菌所引起的呼吸系統、肝膽系統、五官、尿路感染及心內膜炎、敗血症。

注射用頭孢唑肟鈉適應症:敏感菌所致的下呼吸道感染、尿路感染、腹腔感染、盆腔感染、敗血症、皮膚軟組織感染、骨和關節感染、肺炎鏈球菌或流感嗜血桿菌所致腦膜炎和單純性淋病。

公司注射用注射用頭孢硫脒2021年度銷售額為1474.03萬元,佔2021年度主營業務收入的比例為0.23%;注射用頭孢唑肟鈉2021年度銷售額為1.09億元,佔2021年度主營業務收入的比例為1.71%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account